Joseph Patti PhD
President & CEO
Dr. Patti has over twenty years of executive operating experience and played a critical role in raising over $300M in private and public equity. He led multiple R&D teams that successfully filed six Investigational New Drug Applications. Dr. Patti currently serves as President of JP Biotech Advisors, Inc., which provides strategic growth and drug development advice to emerging biotechnology companies. In May 2019, Dr. Patti was named a director at Armata Pharmaceuticals (NYSE: ARMP). Previously, Dr. Patti served as Aviragen Therapeutics’ (NASDAQ: AVIR) President and Chief Executive Officer. Before joining Aviragen, Dr. Patti co-founded Inhibitex, Inc. (NASDAQ: INHX) and served as its Chief Scientific Officer and Senior Vice President of Research and Development from 2007 until it was acquired by Bristol Myers Squibb (NYSE: BMS) in February 2012. Dr. Patti received a BS in Microbiology from the University of Pittsburgh, a MSPH from the University of Miami, School of Medicine and a PhD in Biochemistry from the University of Alabama at Birmingham.
Brad H. Vale PhD, DVM
Founder and General Partner, Strategic Healthcare Investment Partners and Former Head, J&J Development Corporation
Brad H. Vale
Brad is a founder and general partner at Strategic Healthcare Investment Partners (S.H.I.P.) based in Santa Clara, California, and Dublin, Ireland. S.H.I.P. invests in early stage medical device companies. Brad was Head of Johnson & Johnson Development Corporation (JJDC) from 2012 to 2015. JJDC is Johnson & Johnson’s venture investing arm and has investors based in Si-Valley, Boston, Shanghai, London and Tel Aviv. He established JJDC’s west coast office in 1997 and was an investor in medical devices, healthtech, and biotech from 1992-2012. Prior to joining JJDC, Dr. Vale supported Johnson & Johnson’s medical device businesses at the Corporate Office of Science and Technology, leading exploratory efforts in several areas, including biomaterials, intra-operative diagnostics, and lasers in medicine. He began his JNJ career at Ethicon, Inc., a Johnson & Johnson subsidiary, working on preclinical studies in wound closure, microsurgery, new business development, and a coronary artery bypass graft internal venture that was spun out of Ethicon. Dr. Vale has other experience in medical device research and development, including blood-compatible polymers, novel methods for tissue closure, and hyaluronic acid for post-operative adhesion prevention. Dr. Vale received a PhD in Biomedical Engineering from Iowa State University and a Doctor of Veterinary Medicine from Washington State University.
Managing Partner and Co-Founder of Sun Mountain Capital
Brian Birk is Managing Partner and 2006 co-founder of Sun Mountain Capital and has over 20 years experience as an operating executive and investor. Prior to forming Sun Mountain Capital, Birk was Vice President and Director of Private Equity at Fort Washington Capital Partners where he helped the firm establish and manage a number of private equity direct investment funds, secondary investment funds, and fund of funds programs. Birk has held a senior manager position at the Boston Consulting Group and finance manager positions at General Electric and GE Capital. Birk has an MBA from the Kellogg School of Management and a BS in economics from Carleton College.
Faith L. Charles
Partner in Thompson Hine's Corporate Transactions and Securities
Faith L. Charles
Faith Charles, a corporate and securities specialist and law firm partner, has a 25+ year track record of results for public and private companies. Her specialties include corporate counseling and strategic advice in the biotechnology, medical devices, diagnostics and health care information space including: U.S. and global business transactions and technology transfers;Angel and venture capital financings; Private placements; Public offerings (equity and debt); Mergers and acquisitions; Spin-offs, joint ventures, licensing and other strategic collaborations; Alternative financings; Corporate governance; and Compliance with SEC, Amex, Nasdaq and securities regulatory issues. Faith has authored articles and presents on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs. She has been featured in Crain’s New York and profiled in The New York Times. She has earned recognition as a BTI Client Service All-Stars for service excellence, and from LMG Life Sciences for transactional and Life Sciences expertise. Faith is on the board of several early stage companies. Faith has spoken for and served as a panelist and moderator for such organizations as Advamed, Springboard, and North Carolina Biotechnology Center. She has authored articles on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs.
Waneta Tuttle PhD, MBA
Owner and CEO of Southwest Medical Ventures (SMV)
Waneta C. Tuttle, Ph.D., M.B.A. is the owner and CEO of Southwest Medical Ventures (SMV), a life sciences and health care venture development company. Through SMV, she was the founding CEO of Indigo Medical, (acquired by Johnson & Johnson’s Ethicon Endosurgery), PhDx Systems, Inc. and Exagen Diagnostics, Inc. SMV is the managing member of Puente Partners, LLC and Southwest Medical Technologies, LLC (SMT). The Puente Partners portfolio includes nanoMR, Inc. and Azano Pharma, Inc. SMT was organized in 2010 to create new ventures focused on technology spin-offs and roll-ups. SMT's first company is AgilVax, Inc. Until its sale to Eisai Pharmaceuticals, Inc. in January of 2008, Dr. Tuttle served as a Director of NASDAQ listed MGI Pharma, Inc., an oncology and acute care focused biopharmaceutical company. She is a Director of Health Care Service Corporation, a mutual legal reserve company operating Blue Cross/Blue Shield of Illinois, New Mexico, Oklahoma and Texas and is a Member of the Corporation at the Charles Stark Draper Laboratories in Boston. She serves as Southwest Regional Advisor to Tullis Health Investors and to the Tullis-Dickerson funds. Prior to founding SMV in 1992, Dr. Tuttle held positions of increasing responsibility over 23 years at the Lovelace Medical Foundation in Albuquerque. She began her career at the Foundation as a research scientist, and then served for many years as its Vice President and Chief Operating Officer. She was also a member of the management committee for the integrated health care delivery system at Lovelace and served on the Boards of Directors for several of the Lovelace organizations. Dr. Tuttle’s Ph.D. is in biology with a concentration in physiology. She also holds an M.B.A. from the R.O. Anderson Schools of Management at the University of New Mexico and has been inducted into the Anderson Schools Hall of Fame.
Ebetuel Pallares PhD
Chairman of the Board: Founded Joseph Advisory Services (jAS) and co-founded Cottonwood Capital Partners
Dr. Ebetuel Pallares founded Joseph Advisory Services (JAS) in 2006. He brings extensive domestic and international start-up experience as an entrepreneur and in conducting due diligence for both start-ups and late stage companies. His professional experience spans working for top-tier strategy consulting firms, co-founding start-ups, international business development, nonprofit management, venture capital and military service. In the summer of 2009, he co-founded Cottonwood Capital Partners, the general partner of Cottonwood Technology Fund, a seed and early-stage venture fund with headquarters in El Paso, TX. He serves on several corporate and nonprofit boards. He is also an advisor to the UT Horizon Fund, the venture capital investment fund of the University of Texas System, he is the Investor in Residence for NMSU's Arrowhead Center, and serves on the limited partnership advisory committees of several venture funds. He graduated from Brandeis University, in Waltham, MA, with a degree in economics, and received his MBA from The University of Texas at El Paso (UTEP). He also went on to attain a Ph.D. in International Business from UTEP. Dr. Pallares' research has focused on confluence of high tech emerging market firms, incubators and technology commercialization. Dr. Pallares is married, and enjoys fatherhood. When not watching his kids while his wife, a professional photographer, is on assignment, he engages in reading, writing and community service, including service in Rotary International and Gideons International.